| 000 | 01843 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250513215722.0 | ||
| 264 | 0 | _c20000912 | |
| 008 | 200009s 0 0 eng d | ||
| 022 | _a0022-3565 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBond, A | |
| 245 | 0 | 0 |
_aNeuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist: investigations into possible mechanism of action in vivo. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cSep 2000 |
||
| 300 |
_a800-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAmino Acids _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aArterial Occlusive Diseases _xcomplications |
| 650 | 0 | 4 |
_aBrain Ischemia _xdrug therapy |
| 650 | 0 | 4 |
_aBrain-Derived Neurotrophic Factor _xmetabolism |
| 650 | 0 | 4 |
_aBridged Bicyclo Compounds, Heterocyclic _xpharmacology |
| 650 | 0 | 4 |
_aCarotid Artery Diseases _xcomplications |
| 650 | 0 | 4 |
_aExcitatory Amino Acid Agonists _xpharmacology |
| 650 | 0 | 4 | _aGerbillinae |
| 650 | 0 | 4 |
_aHippocampus _xdrug effects |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMotor Activity _xdrug effects |
| 650 | 0 | 4 |
_aNerve Growth Factor _xmetabolism |
| 650 | 0 | 4 |
_aNeurons _xpathology |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
| 650 | 0 | 4 |
_aReceptors, Metabotropic Glutamate _xagonists |
| 650 | 0 | 4 |
_aTransforming Growth Factor beta _xmetabolism |
| 700 | 1 | _aJones, N M | |
| 700 | 1 | _aHicks, C A | |
| 700 | 1 | _aWhiffin, G M | |
| 700 | 1 | _aWard, M A | |
| 700 | 1 | _aO'Neill, M F | |
| 700 | 1 | _aKingston, A E | |
| 700 | 1 | _aMonn, J A | |
| 700 | 1 | _aOrnstein, P L | |
| 700 | 1 | _aSchoepp, D D | |
| 700 | 1 | _aLodge, D | |
| 700 | 1 | _aO'Neill, M J | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 294 _gno. 3 _gp. 800-9 |
|
| 999 |
_c10894606 _d10894606 |
||